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Abstract 
Background: It has been implicated that obstructive sleep apnea (OSA) is associated with 
increased risk of cardiovascular disease including stroke, myocardial infarction, coronary 
artery disease (CAD) and hypertension. The aim of this study was to investigate the 
correlation between OSA and severity of atherosclerosis assessed by angiography. 
Methods: This study included 337 patients undergoing diagnostic coronary angiography at 
Tehran Heart Center, Iran. The Gensini score was obtained from each patient for coronary 
angiogram, and OSA were assessed by using Multivariable apnea prediction (MAP) risk 
index on the day of cardiac catheterization. The Gensini scores increased in accordance 
with increases in the MAP value. 
Results: The prevalence rates of three-vessel disease were 68.0% in OSA group and 32.0% 
in non-OSA group. The MAP index was the most significant independent determinant for 
the Gensini score. 
Conclusions: The independent association between OSA and CAD, even after adjustment 
for traditional confounders, suggests that, OSA should be taken into account when 
considering risk factors for CAD. 
Keywords: Atherosclerosis, Coronary angiography, Coronary artery disease, Gensini 
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Obstructive sleep apnea (OSA), a disorder characterized by snoring and repetitive 
episodes of cessation of breathing during sleep and daytime somnolence, is a prevalent 
condition that affects approximately 13% and 6% of men and  women aged 30-70, 
respectively (1, 2). About 69% of patients with CAD have OSA (3). OSA is defined as an 
apnea/hypopnea index (AHI) of more than 5 events/hour. It has been implicated that 
obstructive sleep apnea is associated with increased risk of cardiovascular disease 
including stroke, myocardial infarction, CAD and hypertension (4-7). To the best of our 
knowledge, the correlation between OSA and CAD has not been angiographically 
confirmed. Studies have emphasized on the important role of diagnosis and treatment of 
OSA in patients with CAD (7, 8). Continuous positive airway pressure (CPAP) ,the gold 
standard therapy for OSA, has been shown to reduce cardiovascular mortality and improve 
cardiovascular risk factors including blood pressure, lipid profile and insulin sensitivity (9-
12). The Iranian population is becoming aged and more obese, two conditions that increase 
the risk of OSA. We aimed to assess the relationship between severity of OSA and 
coronary atherosclerosis by application of coronary artery angiography, Gensini scoring 
evaluation system, and other risk factors which may contribute to CAD. 
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Methods 
Subjects: This study included 337 patients undergoing 
diagnostic coronary angiography at Tehran Heart Center, 
Iran. Exclusion criteria were a prior history of 
revascularization or oxygen therapy, chronic obstructive 
pulmonary disease, daytime hypoxemia and the regular use 
of hypnotic agents. Informed consent was obtained from all 
patients. The protocol was approved by the Ethics 
Committee of Tehran University of Medical Sciences, and 
the study was conducted in conformity with the current 
revision of the Declaration of Helsinki.  
Instruments: The patients' clinical and demographic data 
were gathered by a semi-structured interview, while the 
interviewer was blind to the patient's angiographic results. 
Height, weight and BMI were measured. A family history of 
premature CAD was determined as cardiovascular event in 
<45 years old female or <55 years old male 1st-degree 
relative. Venous blood samples were obtained after at least 
10 hours of overnight fasting. 
Angiographic estimation of coronary atherosclerosis: 
Coronary angiography was performed by the femoral 
approach and included at least 5 views of the left coronary 
artery and 2 views of the right coronary artery. The Gensini 
score which determines the severity of stenosis (13) was 
calculated based on coronary angiogram, and the left 
ventricular ejection fraction was determined from the left 
ventriculogram. The Gensini score was computed by 
assigning a severity score to each coronary stenosis 
according to the degree of luminal narrowing and its 
geographic importance. Lumen diameter reduction of 25%, 
50%, 75%, 90%, 99% and total occlusion are graded as 1, 2, 
4, 8, 16 and 32, respectively. This score is then multiplied by 
a factor that takes into account the importance of the lesion’s 
position in which the more proximal it I,s the higher 
weighting score it receives. The Gensini score was expressed 
as the sum of the scores for all the coronary arteries. The 
subjects were divided into 4 groups according to the Gensini 
score: group A or negative result (Gensini score = 0), group 
B or nominal result (Gensini score ≤ 5), group C (Gensini 
score: 6 - 30) and group D or advanced CAD (Gensini score 
> 30). Patients with one or more stenosis less than 50% were 
defined as having minimal CAD.  
Estimation of obstructive sleep apnea: OSA was assessed 
by using multivariable apnea prediction (MAP) risk index on 
the day of cardiac catheterization. Multiple logistic regression 
models were used to incorporate BMI, age and gender into a 
MAP index. We accepted a threshold MAP index ≥ 0.50 as 
diagnostic of OSA. Thus, the patients were divided into 2 
groups, according to the severity of OSA: OSA group (0.50≤ 
MAP value) and non- OSA group (MAP value < 0.50). 
Definition of the metabolic abnormalities: The metabolic 
syndrome (MetS) was defined as the presence of three or 
more of the following criteria: fasting plasma glucose ≥110 
mg/dl or previous diagnosis of diabetes, HDL-C < 40 mg/dl 
and 50 mg/dl in men and women, respectively, triglycerides 
≥150 mg/dl, blood pressure ≥130/85mmHg or the use of 
antihypertensive drug therapy and overweight[14]. Since 
data on waist circumference were not available, overweight 
is defined as BMI>25 kg/m
2
.  
Statistical analysis: Data were analyzed using SPSS for 
windows statistical package Version 17. Student's t test was 
used to compare continuous variables and chi-square test 
was used to compare categorical variables across the two 
groups. The correlations between variables were studied with 
the Pearson test. Multiple linear regression analysis was used 
to assess the relationship between MAP index and Gensini 
score adjusted for the effects of age, gender, family history 
of CAD, smoking or opium addiction status, hypertension, 
diabetes, hyperlipidemia, BMI or the presence of MetS. 
Multiple, stepwise, linear regression analysis also was 
performed to identify which variables best explained the 
variance in the Gensini score. A p-value of < 0.15 was first 
used to identify candidate variables, and then removed 
variables from the regression model if p value was < 0.1. A 
p<0.05 was considered significant. 
 
 
Results 
337 patients (169 men, 168 women) with the mean age of 
57±11 years were included. Sleep studies revealed OSA in 
119 (35.3%) patients with a MAP value of 0.50 and higher. 
Clinical characteristics and serum profiles of patients in the 
two study groups are summarized in table 1. Normal coronary 
angiography was found in 19.3%, nominal angiographic 
findings in 7.4%, and positive angiographic findings in 73.3%. 
Subjects with OSA were older and SBP, serum levels of 
triglycerides and total cholesterol and BMI was significantly 
higher and the level of HDL-C was lower in this group. 
There were no significant differences regarding DBP, fasting 
plasma glucose, family history of ischemic heart disease, 
smoking or opium addiction history between two groups 
(table 1).  
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Table 1. Clinical and metabolic characteristics of the study subjects with and without sleep apnea. 
 
Characteristics Positive sleep 
apnea study 
MAP index ≥ 
0.50 
Negative sleep 
apnea study 
MAP index < 0.50 
Pvalue 
 
Patients, No. 119 218  
Age, year 59.9±10. 4 55.5±11.1 <0.001 
Gender 
             Male 
Fe              Female 
 
87 (73.1%) 
 
82 (37.6%) 
 
<0.001 
32 (26.9%) 136 (62.4%) 
Body mass index (kg/m
2
) 30. 5 ± 6.6 26.6 ± 3.7 <0.001 
Smoking 11 (9.2%) 32 (14.7%) 0.174 
Opium addiction 1 (0.8%) 5 (2.3%) 0.430 
Family history 17 (14.3%) 49 (22.5%) 0.085 
Systolic blood pressure, mmHg 139.7 ± 20.3 134.2 ± 18.4 0.012 
Diastolic blood pressure, mmHg 83.2 ± 12.5 82.1 ± 12.1 0.420 
Subjects with hypertension 71(59.7 %) 108 (49.5 %) 0.048 
Triglycerides, mg/dL 208.1 ± 121.1 168.5 ± 99.3 0.003 
Total cholesterol, mg/dL 186.2 ± 51.3 171.2 ± 52.8 0.012 
HDL-cholesterol, mg/dL 38.7 ± 9.8 43.8 ±11.5 <0.001 
Dyslipidemia  102 (85.7%) 163 (74.8%) 0.026 
Fasting blood glucose, mg/dL 118.4 ± 39.9 116.7 ± 69.1 0.811 
Hyperglycemia  32 (26.9%) 46 (21.1%) 0.280 
Subjects with at least three of the following: hypertension, hyperglycemia, 
overweight high triglyceride and low HDL-cholesterol values 
80 (67.2%) 106 (48.6%) 0.001 
Data are presented as the means ± SD or as numbers and percentages. HDL;high-density lipoprotein, MAP; multivariable apnea risk.
 
The Gensini scores increased in accordance with 
increases in the MAP value, and the scores in OSA group 
were significantly higher than those in non-OSA group 
(figures 1 and 2).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The Gensini scores increased in accordance 
with increases in the Multivariable Apnea risk index value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The Gensini scores in apnea group was 
significantly higher than those in non-apnea group 
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Table 2 shows a comparison of coronary angiography 
and left ventriculography data across the MAP value 
quartiles. The prevalence of three-vessel disease was 68.0% 
in OSA group and 32.0% in non-OSA group. The proportion 
of patients with OSA also increased across the four CAD 
severity groupings (table 2). MAP value and coronary 
angiography data progressively worsened in subgroups with 
progressive increases of BMI (data not shown). Although 
MAP index is used mostly as dichotomous variable for the 
qualitative estimation of OSA, there was a linear trend effect 
of association with MetS as the severity of OSA increased in 
terms of MAP. A significant relationship between a higher 
MAP index with the increase in the number of features of 
MetS in the whole study group was also demonstrated 
(P<0.05). Univariate analysis showed that MAP was significantly 
associated with Gensini score. The association of Gensini 
score with MAP index both unadjusted and adjusted for the 
effect of other risk factors is displayed in table 3. 
 
Table 2. A Comparison of coronary arteriography and left ventriculography data across the levels of sleep apnea severity 
Variable 
 
Positive sleep apnea study 
MAP index ≥ 0.50 
Negative sleep apnea study 
MAP index < 0.50 
Diseased vessels, No.   
Minimal CAD 33 (27.7) 141 (64.7) 
Single vessel disease 46 (38.7) 49 (22.5) 
Two vessels disease 22 (18.5) 19 (8.7) 
Three vessels disease 17 (14.3) 8 (3.7) 
Left main leision 1 (0.8) 1 (0.5) 
Gensini score   
Total score 109.55 ± 60.49 33.58 ± 47.28 
Score = 0 6 (5) 59 (27.1) 
Score ≤ 5 5 (4.2) 20 (9.2) 
Score: 6 – 30 3 (2.5) 51 (23.4) 
Score > 30 105 (88.2) 88 (40.4) 
Ejection fraction, % 46.07 ± 13.32 50.44 ± 12.45 
 
Table 3. Association of sleep apnea alone or with control variablesiIntroduced with a measure of coronary artery severity (Gensini score) 
 Model 1
a
 Model 2
b
 Model 3
c
 
Univariate (r) P value Multivariate (ß) P value Multivariate (ß) P value 
Age, yr 0.208 <0.001 0.148 0.001 0.138 0.002 
Male (0 = no, 1 = yes) 0.344 <0.001 0.282 <0.001 0.268 <0.001 
Body mass index (kg/m2) 0.256 <0.001 0.191 <0.001 0.192 <0.001 
Smoking (0 = no, 1 = yes) 0.046 0.399 -0.020 0.689   
Opium addiction (0 = no, 1 = yes) 0.201 <0.001 0.190 <0.001 0.187 <0.001 
Family history (0 = no, 1 = yes) 0.050 0.363 0.093 0.032 0.090 0.031 
Systolic blood pressure 0.078 0.153 -0.046 0.396   
Diastolic blood pressure 0.032 0.561 -0.007 0.894   
Total cholesterol 0.093 0.089 0.003 0.945   
Triglycerides 0.138 0.011 0.01 0.845   
HDL-cholesterol -0.155 0.004 0.04 0.41   
Fasting blood glucose 0.073 0.181 0.051 0.234   
Metabolic syndrome 0.197 <0.00 0.121 0.026 0.103 0.021 
Sleep apnea, MAP index 0.596 <0.001 0.377 <0.001 0.376 <0.001 
a Model 1: unadjusted estimate of Gensini score. 
b Model 2: adjusted for age, gender, family history, smoking or addiction status, hypertension, diabetes, hyperlipidemia, BMI or the presence of MetS. 
c Model 3: Multiple, stepwise, linear regression to identify best variables explaining the variance in the Gensini score. 
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Discussion 
In the present study, we have investigated the OSA 
estimated by MAP index as a correlation of severity of 
coronary artery disease verified by Gensini score. We found 
the Gensini score is significantly higher in patients with an 
increased risk of apnea. In addition, the proportion of 
patients with OSA increased with severity of CAD, from 
19.8%% among the negative angiographic subjects or 
minimal CAD to 68.0% among the patients with three vessel 
disease. Furthermore, although, the prevalence and 
components of MetS including high blood pressure, high 
fasting blood glucose level and dyslipidemia increase while 
the severity of OSA increases, multiple regression analysis 
of coronary risk factors showed that the OSA verified by 
MAP index was the most significant independent 
determinant of the severity of coronary atherosclerosis. A 
growing bulk of evidence from studies has been suggesting 
that OSA is an independent risk factor for CAD (7).  
The result of our study in an Iranian sample was similar 
to the research studies of Gan et al.(15), Hayashi et al. (16) 
and Inami et al. (17) which revealed a positive correlation 
between Gensini score and the severity of OSA. Hayashi et 
al. (16) examined the relation between nocturnal oxygen 
desaturation index (ODI) and the Gensini score in patients 
with CAD diagnosed by coronary angiography. Multiple 
regression analysis showed that the ODI was the most 
significant, independent determinant of the Gensini score 
among the coronary risk factors tested. There is growing 
experimental and clinical evidence for an independent 
association of OSA with the development and/or severity of 
MetS. On the contrary, MetS and its components—in 
particular, obesity, hypertension and insulin resistance—may 
have conductive influence on the development of OSA. The 
connection between obesity and OSA may be mutually 
perpetuating. 
 The exact mechanisms by which obesity may increase 
the risk of OSA or vice versa are still obscure. The 
detrimental effects of fat deposition on upper airway 
anatomy and its function, and leptin resistance have been 
suggested (18-21). Considerable overlap between OSA and 
obesity makes it difficult to identify the role each plays in 
many cardiovascular diseases. The association between OSA 
and insulin resistance, a putative background of the MetS, 
has been investigated in a number of reports (22, 23). The 
severity of OSA may affect insulin resistance to a greater 
extent in nonobese patients with OSA, indicating that OSA 
per se may be associated with insulin resistance, although 
concomitant obesity or visceral fat accumulation are 
predominant risk factors for insulin resistance (24, 25). The 
increasing recognition and acceptance of a link between 
OSA and MetS prompts the question of whether OSA occurs 
as part of the fundamental pathophysiology of MetS, or 
OSA, via repetitive nocturnal hypoxemia, systemic 
inflammation, and other mechanisms, promotes the 
components of MetS.  
Therefore studies on the association between OSA and 
cardiovascular sequelae need to be controlled for these 
important potential confounders. In our study, the percentage 
of patients presenting at least two metabolic abnormalities 
was significantly higher in the OSA group. OSA patients 
with MetS had higher degrees of Gensini score. As discussed 
in detail above, the impact of potential confounders was 
carefully controlled in the present study. The strength of the 
association between OSA and CAD severity was decreased 
by about 18% via introducing the confounding factors, but 
remained significant and MAP index was the most 
significant independent determinant for the Gensini score. 
Assuming OSA precedes CAD, the relationship of OSA and 
CAD may be explained by several mechanisms including 
hemodynamic changes (brady tachycardia, hypoxi 
chypertensive episodes) and sympathetic hyperactivity 
which may in turn evoke endothelial damage via mechanical 
strain, vasospasm and thrombogenesis (26-29). Also, 
repetitive hypoxia cause oxidative stress which then results 
in lipid peroxidation,  
 
generation of inflammatory agents and 
all these factors can promote the development of 
atherosclerosis (18, 30-33).  
 Some limitations need to be considered when 
interpreting the results of this study. We did not have access 
to measurements of waist circumference. Hence, the 
prevalence of MetS might be higher than   what we found in 
this study. Because of the design of our study, we cannot 
establish causality. The diagnosis of OSA in our study was 
made based on MAP index. 
 Although MAP index has been extensively used in 
different investigations to assess OSA with a good sensitivity 
and specificity (34), polysomnographic study was not 
performed to confirm the diagnosis. In addition, the results 
of this study cannot be extrapolated to other ethnic groups. 
Undoubtedly, well- designed prospective crossover controlled 
studies with larger samples and longer follow-up and 
rigorous characterization of subjects would be required to 
 Caspian J Intern Med 2018; 9(3):276-282  
Sleep apnea and coronary artery disease                    281 
further elucidate the link between OSA and CAD, as well as 
the associated mechanisms.  
In conclusion these data suggest a high prevalence of 
OSA in CAD patients. The independent association between 
OSA and CAD, even after adjustment for traditional 
confounders, suggests that great attention should be paid to 
the screening of OSA when considering the risk factors for 
CAD, as OSA can easily be diagnosed, and in many cases 
represents a readily treatable condition. The high prevalence 
of OSA and the morbidity and mortality thought to be 
associated with it, have resulted in a view that OSA may be 
as big a public health hazard as smoking and purchasers are 
increasingly being urged to support sleep services.  
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